Catheter Precision, Inc.
VTAK- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716621
No open-market purchases or sales by Catheter Precision, Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $57.2K in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Catheter Precision, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −5 vs. Q1 2021
- Shares held
- 446.6K
- −378.1K (−45.9%) vs. Q1 2021
- Total value
- $1.95M
- −$1.89M (−49.2%) vs. Q1 2021
- New holders
- 5
- 6 more added
- Sold out
- 10
- 1 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTAK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $57.2K |
| Q1 2026 | 12 | $102.9K |
| Q4 2025 | 9 | $125.2K |
| Q3 2025 | 3 | $58 |
| Q2 2025 | 12 | $120.2K |
| Q1 2025 | 10 | $202.3K |
| Q4 2024 | 8 | $216.7K |
| Q3 2024 | 11 | $62.8K |
| Q2 2024 | 14 | $414.5K |
| Q1 2024 | 13 | $389.4K |
| Q4 2023 | 13 | $176.5K |
| Q3 2023 | 14 | $240.8K |
| Q2 2023 | 14 | $382.8K |
| Q1 2023 | 11 | $904.4K |
| Q4 2022 | 12 | $469.9K |
| Q3 2022 | 21 | $292.2K |
| Q2 2022 | 23 | $256.5K |
| Q1 2022 | 26 | $420.0K |
| Q4 2021 | 23 | $1.04M |
| Q3 2021 | 19 | $1.50M |
| Q2 2021 | 15 | $1.95M |
| Q1 2021 | 20 | $3.84M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Catheter Precision, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 18 | $0 | 0.00% | +1+5.9% | Added |
| Royal Bank of Canada | 157 | $1.00K | 0.00% | +157 | New |
| CVA Family Office, LLC | 200 | $1.00K | 0.00% | +200 | New |
| Morgan Stanley | 535 | $2.00K | 0.00% | −14,671−96.5% | Reduced |
| Advisor Group Holdings, Inc. | 839 | $4.00K | 0.00% | +176+26.5% | Added |
| State Street Corp | 10,300 | $45.0K | 0.00% | +10,300 | New |
| MANA Advisors LLC | 10,334 | $45.0K | 4.04% | +10,334 | New |
| Alethea Capital Management, LLC | 12,320 | $54.0K | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 14,830 | $64.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 15,970 | $70.0K | 0.00% | +7,189+81.9% | Added |
| Two Sigma Securities, LLC | 16,822 | $74.0K | 0.02% | +16,822 | New |
| Virtu Financial LLC | 61,551 | $269.0K | 0.03% | +32,128+109.2% | Added |
| Dowling & Yahnke LLC | 68,448 | $299.0K | 0.02% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 89,101 | $389.0K | 0.04% | +39,624+80.1% | Added |
| Vanguard Group Inc | 145,161 | $634.0K | 0.00% | +106,451+275.0% | Added |
| Royce & Associates LP | 0 | $0 | 0.00% | −317,583−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −155,502−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −33,000−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −20,600−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −19,079−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −17,116−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,517−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,244−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −202−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |